About Cardival Medical
Cardival Medical is a company based in Santa Clara (United States) founded in 2002 was acquired by Haemonetics in January 2021.. Cardival Medical has raised $169.45 million across 13 funding rounds from investors including Haemonetics, GE Capital and WI Harper Group. The company has 158 employees as of December 31, 2022. Cardival Medical offers products and services including Cell Saver, TEG 6s, and VASCADE. Cardival Medical operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Saranas and Aziyo Biologics, among others.
- Headquarter Santa Clara, United States
- Employees 158 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cardiva Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$169.45 M (USD)
in 13 rounds
-
Latest Funding Round
$45 M (USD), Series E
Jul 14, 2020
-
Investors
Haemonetics
& 9 more
-
Employee Count
158
as on Dec 31, 2022
-
Acquired by
Haemonetics
(Jan 20, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cardival Medical
Cardival Medical offers a comprehensive portfolio of products and services, including Cell Saver, TEG 6s, and VASCADE. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for recovering blood during surgical procedures
System for monitoring and analyzing blood clotting functions
Tool for sealing vascular access sites post-procedure
Funding Insights of Cardival Medical
Cardival Medical has successfully raised a total of $169.45M across 13 strategic funding rounds. The most recent funding activity was a Series E round of $45 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series E — $45.0M
-
First Round
First Round
(01 Nov 2003)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series E - Cardival Medical | Valuation |
investors |
|
| Feb, 2018 | Amount | Debt – Conventional - Cardival Medical | Valuation |
investors |
|
| Feb, 2018 | Amount | Series D - Cardival Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cardival Medical
Cardival Medical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Haemonetics, GE Capital and WI Harper Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in expansion & late stage start-ups in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investment management services are provided by Luther King Capital Management.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cardival Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cardival Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cardival Medical Comparisons
Competitors of Cardival Medical
Cardival Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Saranas and Aziyo Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| domain | founded_year | HQ Location |
AV fistula maturation and patency are supported by VasQ device.
|
|
| domain | founded_year | HQ Location |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| domain | founded_year | HQ Location |
A device is developed for detecting internal bleeding during catheterization.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cardival Medical
Frequently Asked Questions about Cardival Medical
When was Cardival Medical founded?
Cardival Medical was founded in 2002 and raised its 1st funding round 1 year after it was founded.
Where is Cardival Medical located?
Cardival Medical is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Is Cardival Medical a funded company?
Cardival Medical is a funded company, having raised a total of $169.45M across 13 funding rounds to date.
How many employees does Cardival Medical have?
As of Dec 31, 2022, the latest employee count at Cardival Medical is 158.
What does Cardival Medical do?
Cardival Medical was founded in 2002 in Santa Clara, United States, where medical devices for vascular access are developed. Operations center on two products: Vascade, an extravascular bioabsorbable femoral access closure system, and CATALYST, used for temporary hemostasis and coagulation support in patients. The focus remains on vascular sector innovations, with activities based in the United States.
Who are the top competitors of Cardival Medical?
Cardival Medical's top competitors include TISSIUM, Vivasure Medical and Aziyo Biologics.
What products or services does Cardival Medical offer?
Cardival Medical offers Cell Saver, TEG 6s, and VASCADE.
Who are Cardival Medical's investors?
Cardival Medical has 10 investors. Key investors include Haemonetics, GE Capital, WI Harper Group, PTV Healthcare Capital, and Canepa Healthcare.